Search Results

There are 25365 results for: content related to: From prostate-specific antigen ( PSA ) to precursor PSA ( proPSA ) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer

  1. Updating risk prediction tools: A case study in prostate cancer

    Biometrical Journal

    Volume 54, Issue 1, January 2012, Pages: 127–142, Donna P. Ankerst, Tim Koniarski, Yuanyuan Liang, Robin J. Leach, Ziding Feng, Martin G. Sanda, Alan W. Partin, Daniel W. Chan, Jacob Kagan, Lori Sokoll, John T. Wei and Ian M. Thompson

    Version of Record online : 17 NOV 2011, DOI: 10.1002/bimj.201100062

  2. You have free access to this content
    Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study

    BJU International

    Volume 115, Issue 6, June 2015, Pages: 913–920, Nicola Fossati, Massimo Lazzeri, Alexander Haese, Thomas McNicholas, Alexandre de la Taille, Nicolò Maria Buffi, Giovanni Lughezzani, Giulio Maria Gadda, Giuliana Lista, Alessandro Larcher, Alberto Abrate, Francesco Mistretta, Vittorio Bini, Joan Palou Redorta, Markus Graefen and Giorgio Guazzoni

    Version of Record online : 26 MAR 2015, DOI: 10.1111/bju.12718

  3. You have free access to this content
    Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer

    BJU International

    Volume 117, Issue 1, January 2016, Pages: 12–13, Robert W. Veltri

    Version of Record online : 10 DEC 2015, DOI: 10.1111/bju.13151

  4. Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml

    The Prostate

    Volume 72, Issue 15, November 2012, Pages: 1611–1621, Giuseppe Lucarelli, Margherita Fanelli, Angela Maria Vittoria Larocca, Cinzia Annatea Germinario, Monica Rutigliano, Antonio Vavallo, Francesco Paolo Selvaggi, Carlo Bettocchi, Michele Battaglia and Pasquale Ditonno

    Version of Record online : 16 MAR 2012, DOI: 10.1002/pros.22514

  5. You have free access to this content
    Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study

    BJU International

    Volume 115, Issue 4, April 2015, Pages: 537–545, Alberto Abrate, Massimo Lazzeri, Giovanni Lughezzani, Nicolòmaria Buffi, Vittorio Bini, Alexander Haese, Alexandre de la Taille, Thomas McNicholas, Joan Palou Redorta, Giulio M. Gadda, Giuliana Lista, Ella Kinzikeeva, Nicola Fossati, Alessandro Larcher, Paolo Dell'Oglio, Francesco Mistretta, Massimo Freschi and Giorgio Guazzoni

    Version of Record online : 25 MAR 2015, DOI: 10.1111/bju.12907

  6. A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases

    The Prostate

    Volume 69, Issue 2, 1 February 2009, Pages: 198–207, Carsten Stephan, Anna-Maria Kahrs, Henning Cammann, Michael Lein, Mark Schrader, Serdar Deger, Kurt Miller and Klaus Jung

    Version of Record online : 21 OCT 2008, DOI: 10.1002/pros.20872

  7. Establishment of a mammalian expression system for recombinant [–2]proPSA and a specific antibody against the truncated leader peptide

    Biotechnology and Applied Biochemistry

    Volume 64, Issue 3, MAY/JUNE 2017, Pages: 327–336, Dobeen Hwang, Aerin Yoon, Soohyun Kim, Hyori Kim and Junho Chung

    Version of Record online : 10 JUN 2016, DOI: 10.1002/bab.1481

  8. You have free access to this content
    Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

    BJU International

    Volume 112, Issue 5, September 2013, Pages: 602–609, Sigrid V. Carlsson, Mari T. Peltola, Daniel Sjoberg, Fritz H. Schröder, Jonas Hugosson, Kim Pettersson, Peter T. Scardino, Andrew J. Vickers, Hans Lilja and Monique J. Roobol

    Version of Record online : 28 FEB 2013, DOI: 10.1111/j.1464-410X.2012.11690.x

  9. You have free access to this content
    Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: Focusing on Asians and Asian countries

    International Journal of Urology

    Volume 22, Issue 4, April 2015, Pages: 334–341, Koji Okihara, Atsushi Ochiai, Kazumi Kamoi, Yuji Fujizuka, Tsuneharu Miki and Kazuto Ito

    Version of Record online : 1 APR 2015, DOI: 10.1111/iju.12701

  10. You have free access to this content
    The role of prostate-specific antigen in the clinical evaluation of prostatic disease

    BJU International

    Volume 93, Issue s1, March 2004, Pages: 10–15, S.R. Denmeade and J.T. Isaacs

    Version of Record online : 17 FEB 2004, DOI: 10.1111/j.1464-410X.2003.04634.x

  11. Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy

    The Prostate

    Volume 73, Issue 3, 15 February 2013, Pages: 227–235, Sisto Perdonà, Dario Bruzzese, Matteo Ferro, Riccardo Autorino, Ada Marino, Claudia Mazzarella, Giuseppe Perruolo, Michele Longo, Rosa Spinelli, Giuseppe Di Lorenzo, Andrea Oliva, Marco De Sio, Rocco Damiano, Vincenzo Altieri and Daniela Terracciano

    Version of Record online : 20 JUL 2012, DOI: 10.1002/pros.22561

  12. You have free access to this content
    Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure

    Clinical Cardiology

    Volume 40, Issue 7, July 2017, Pages: 485–491, Moritz Schanz, Jing Shi, Christoph Wasser, Mark Dominik Alscher and Martin Kimmel

    Version of Record online : 10 MAR 2017, DOI: 10.1002/clc.22683

  13. Mutational Analysis of Prostate-Specific Antigen Defines the Intrinsic Proteolytic Activity of the proPSA Zymogen

    The Prostate

    Volume 76, Issue 13, September 15, 2016, Pages: 1203–1217, Niquiche Sangster-Guity, Becky Tu-Sekine, Daniel M. Raben, Samuel R. Denmeade and Simon A. Williams

    Version of Record online : 8 JUN 2016, DOI: 10.1002/pros.23216

  14. Performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital-based biopsy population

    The Prostate

    Volume 74, Issue 15, November 2014, Pages: 1569–1575, Rong Na, Dingwei Ye, Fang Liu, Haitao Chen, Jun Qi, Yishuo Wu, Guiming Zhang, Meilin Wang, Wenying Wang, Jielin Sun, Guopeng Yu, Yao Zhu, Shancheng Ren, S. Lilly Zheng, Haowen Jiang, Yinghao Sun, Qiang Ding and Jianfeng Xu

    Version of Record online : 31 AUG 2014, DOI: 10.1002/pros.22876

  15. Micelles with highly branched nanoporous interior: Solution properties and binding capabilities of amphiphilic copolymers with linear dendritic architecture

    Journal of Polymer Science Part A: Polymer Chemistry

    Volume 38, Issue 15, 1 August 2000, Pages: 2711–2727, Ivan Gitsov, Kevin R. Lambrych, Victoria A. Remnant and Richard Pracitto

    Version of Record online : 14 JUN 2000, DOI: 10.1002/1099-0518(20000801)38:15<2711::AID-POLA110>3.0.CO;2-1

  16. You have free access to this content
    Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project

    BJU International

    Volume 112, Issue 3, August 2013, Pages: 313–321, Massimo Lazzeri, Alexander Haese, Alberto Abrate, Alexandre de la Taille, Joan Palou Redorta, Thomas McNicholas, Giovanni Lughezzani, Giuliana Lista, Alessandro Larcher, Vittorio Bini, Andrea Cestari, Nicolòmaria Buffi, Markus Graefen, Olivier Bosset, Philippe Le Corvoisier, Alberto Breda, Pablo de la Torre, Linda Fowler, Jacques Roux and Giorgio Guazzoni

    Version of Record online : 4 JUL 2013, DOI: 10.1111/bju.12217

  17. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer

    BJU International

    Spyridon P. Basourakos, John W. Davis, Brian F. Chapin, John F. Ward, Curtis A. Pettaway, Louis L. Pisters, Neema Navai, Mary F. Achim, Xuemei Wang, Hsiang-Chun Chen, Seungtaek Choi, Deborah Kuban, Patricia Troncoso, Sam Hanash, Timothy C. Thompson and Jeri Kim

    Version of Record online : 16 AUG 2017, DOI: 10.1111/bju.13963

  18. You have free access to this content
    The percentage of prostate-specific antigen (PSA) isoform [–2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years

    BJU International

    Volume 117, Issue 1, January 2016, Pages: 72–79, Martin Boegemann, Carsten Stephan, Henning Cammann, Sébastien Vincendeau, Alain Houlgatte, Klaus Jung, Jean-Sebastien Blanchet and Axel Semjonow

    Version of Record online : 24 MAY 2015, DOI: 10.1111/bju.13139

  19. Stability of [−2]Pro-PSA in Whole Blood and Serum: Analysis for Optimal Measurement Conditions

    Journal of Clinical Laboratory Analysis

    Volume 28, Issue 4, July 2014, Pages: 315–319, Tsukasa Igawa, Kosuke Takehara, Toru Onita, Kazuto Ito and Hideki Sakai

    Version of Record online : 27 FEB 2014, DOI: 10.1002/jcla.21687

  20. You have free access to this content
    In situ lung perfusion is a valuable tool to assess lungs from donation after circulatory death donors category I–II

    Transplant International

    Volume 26, Issue 5, May 2013, Pages: 485–492, Caroline Van De Wauwer, Anita J. Munneke, Gerwin E. Engels, Foke M. Berga, Gerhard Rakhorst, Maarten W. Nijsten, Massimo A. Mariani and Michiel E. Erasmus

    Version of Record online : 6 FEB 2013, DOI: 10.1111/tri.12068

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 26, Issue 8, e76, Version of Record online: 16 JUL 2013